Research ArticleOncology
First-in-Humans Trial of Dasatinib-Derivative Tracer for Tumor Kinase-Targeted PET
Simone Krebs, Darren R. Veach, Lukas M. Carter, Milan Grkovski, Monica Fornier, Michael J. Mauro, Martin H. Voss, Daniel C. Danila, Eva Burnazi, Manda Null, Kevin Staton, Christina Pressl, Bradley J. Beattie, Pat Zanzonico, Wolfgang A. Weber, Serge K. Lyashchenko, Jason S. Lewis, Steven M. Larson and Mark P.S. Dunphy
Journal of Nuclear Medicine November 2020, 61 (11) 1580-1587; DOI: https://doi.org/10.2967/jnumed.119.234864
Simone Krebs
1Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York
Darren R. Veach
1Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York
2Department of Radiology, Weill Cornell Medicine, New York, New York
Lukas M. Carter
1Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York
Milan Grkovski
3Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, New York
Monica Fornier
4Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York
5Department of Medicine, Weill Cornell Medicine, New York, New York
Michael J. Mauro
4Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York
5Department of Medicine, Weill Cornell Medicine, New York, New York
Martin H. Voss
4Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York
5Department of Medicine, Weill Cornell Medicine, New York, New York
Daniel C. Danila
4Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York
5Department of Medicine, Weill Cornell Medicine, New York, New York
Eva Burnazi
1Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York
6Radiochemistry and Molecular Imaging Probes Core, Memorial Sloan Kettering Cancer Center, New York, New York
Manda Null
1Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York
Kevin Staton
1Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York
6Radiochemistry and Molecular Imaging Probes Core, Memorial Sloan Kettering Cancer Center, New York, New York
Christina Pressl
7Laboratory of Neural Systems, Rockefeller University, New York, New York
Bradley J. Beattie
3Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, New York
Pat Zanzonico
3Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, New York
Wolfgang A. Weber
1Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York
2Department of Radiology, Weill Cornell Medicine, New York, New York
8Department of Nuclear Medicine, Technical University of Munich, Munich, Germany; and
Serge K. Lyashchenko
1Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York
2Department of Radiology, Weill Cornell Medicine, New York, New York
6Radiochemistry and Molecular Imaging Probes Core, Memorial Sloan Kettering Cancer Center, New York, New York
Jason S. Lewis
1Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York
2Department of Radiology, Weill Cornell Medicine, New York, New York
6Radiochemistry and Molecular Imaging Probes Core, Memorial Sloan Kettering Cancer Center, New York, New York
9Molecular Pharmacology Program, Sloan Kettering Institute, New York, New York
Steven M. Larson
1Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York
2Department of Radiology, Weill Cornell Medicine, New York, New York
9Molecular Pharmacology Program, Sloan Kettering Institute, New York, New York
Mark P.S. Dunphy
1Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York
2Department of Radiology, Weill Cornell Medicine, New York, New York

Data supplements
Supplemental Data
Files in this Data Supplement:
In this issue
Journal of Nuclear Medicine
Vol. 61, Issue 11
November 1, 2020
First-in-Humans Trial of Dasatinib-Derivative Tracer for Tumor Kinase-Targeted PET
Simone Krebs, Darren R. Veach, Lukas M. Carter, Milan Grkovski, Monica Fornier, Michael J. Mauro, Martin H. Voss, Daniel C. Danila, Eva Burnazi, Manda Null, Kevin Staton, Christina Pressl, Bradley J. Beattie, Pat Zanzonico, Wolfgang A. Weber, Serge K. Lyashchenko, Jason S. Lewis, Steven M. Larson, Mark P.S. Dunphy
Journal of Nuclear Medicine Nov 2020, 61 (11) 1580-1587; DOI: 10.2967/jnumed.119.234864
First-in-Humans Trial of Dasatinib-Derivative Tracer for Tumor Kinase-Targeted PET
Simone Krebs, Darren R. Veach, Lukas M. Carter, Milan Grkovski, Monica Fornier, Michael J. Mauro, Martin H. Voss, Daniel C. Danila, Eva Burnazi, Manda Null, Kevin Staton, Christina Pressl, Bradley J. Beattie, Pat Zanzonico, Wolfgang A. Weber, Serge K. Lyashchenko, Jason S. Lewis, Steven M. Larson, Mark P.S. Dunphy
Journal of Nuclear Medicine Nov 2020, 61 (11) 1580-1587; DOI: 10.2967/jnumed.119.234864
Jump to section
Related Articles
Cited By...
- No citing articles found.